Syenex

Evanston, IL · Founded 2022 · Privately Held (backing)

Developer of bioengineering technologies designed to improve the precision and effectiveness of therapeutic cell engineering. Syenex is based in Evanston, IL and was founded in 2022. It was valued at $22 million at its seed round in Jan 2025, the last priced event on record. It has raised $13.7 million across 2 recorded rounds; the latest was an $8.7 million early-stage round in Jan 2025.

PMV mark · valuation
$22.0M
Oct 2026
Priced at
its seed round
Jan 2025
Total raised
$13.7M
Last round
Early Stage VC
Jan 2025
How much has Syenex raised?
$13.7Macross 2 recorded rounds · Jun 2022 – Jan 2025

Most recently, Syenex raised $8.7M in its Early Stage VC (Jan 2025).

Free account
More of Syenex with a free account
  • ·Watch Syenex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Syenex round by round

2 rounds
Jan 2025Early Stage VC$8.7MSEC filing▮
18 investors participated
Jun 2022Early Stage VC$5.0MSEC filing▮
14 investors participated

How much has Syenex raised?

Syenex has raised $13.7 million across 2 recorded rounds since 2022. The largest was an $8.7 million early-stage round in Jan 2025.

Syenex has filed 3 Form Ds with the SEC since 2022, most recently in Jan 2025 ($8.7 million sold to 18 investors).

Syenex investors

9 investors are on record for Syenex, including MedTech Innovator, AlleyCorp, Lightbank (Venture Capital) and Constellation Technology Ventures. The early-stage round in Jan 2025 drew 18 investors.

For fundraisers
Raising for a company like Syenex?

9 investors have backed Syenex.

See all 9 investors →

Frequently asked about Syenex

How much has Syenex raised?
Syenex has raised $13.7M in total across 2 recorded funding rounds.
When was Syenex's last funding round?
Syenex's most recent recorded round was Early Stage VC in Jan 2025, raising $8.7M.